首頁 > 市場調查報告書 > 製藥

癌症

市場調查報告書

商品編碼

1521393

全球聽神經瘤市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Acoustic Neuroma Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 174 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

預計到 2032 年，全球聽神經瘤市場的市場規模將從 2023 年的 20.4 億美元達到近 40.6 億美元，2024-2032 年研究期間複合年成長率為 7.96%。

聽神經瘤是一種非癌性生長，發生在第八腦神經上，將內耳直接連接到大腦。這種生長緩慢的腫瘤由雪旺細胞產生，雪旺細胞產生覆蓋神經纖維的髓鞘。症狀通常包括聽力損失、耳鳴（耳鳴）和平衡障礙。在某些情況下，它可能會導致臉部麻木或無力。雖然其確切原因尚不清楚，但遺傳因素（例如 2 型神經纖維瘤病 (NF2)）可能會增加風險。治療方案各不相同，可能包括定期監測、手術切除或放射治療，取決於腫瘤大小、生長速度和患者整體健康狀況等因素。

市場動態

聽神經瘤盛行率的增加是推動市場成長的主要因素。隨著診斷技術的進步，更多的聽神經瘤病例被及早發現，導致對有效治療的更高需求。微創手術和立體定位放射外科等外科手術的創新顯著改善了患者的治療效果，推動了市場的發展。患者和醫療保健提供者對這種情況及其症狀的認知不斷提高，導致診斷和介入更加頻繁。人口老化是另一個關鍵因素，因為這種情況更有可能發生在老年人身上。此外，政府對聽神經瘤和相關神經系統疾病研究的措施和資助為市場擴張提供了重要動力。研究機構和製藥公司合作開發新療法在推動市場成長方面也發揮著至關重要的作用。醫療保健基礎設施投資的增加，特別是在發展中國家，預計將提供新的市場機會。然而，高昂的治療成本和潛在的副作用可能會挑戰未來幾年的市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球聽神經瘤市場的每個細分市場進行了包容性評估。聽神經瘤產業的成長和趨勢為這項研究提供了整體方法。

市場區隔

聽神經瘤市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按產品分類

裝置
藥物（全身性類固醇、抗病毒藥物、血管擴張劑其他）

依疾病類型

傳導性聽力損失
感音神經性混合性聽損失
混合（傳導性和感音神經性）

按最終用戶

醫院
耳科診所
門診診所

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲聽神經瘤市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。聽神經瘤市場的主要參與者包括F. Hoffmann-La Roche AG、Amgen、Roche、Natus Medical Incorporated、Elekta、Natus Medical Incorporated、輝瑞公司、Civco Medical Solutions、Novartis AG、Maico Diagnostics GmbH、Siemens Healthcare GmbH、 Interacoustics A /S。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：聽神經瘤公司的競爭格局

聽神經瘤市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

頂級公司市佔率分析
市場集中度
F. Hoffmann-La Roche AG

公司簡介
公司收入
產品
最近的發展

Amgen

公司簡介
公司收入
產品
最近的發展

Roche

公司簡介
公司收入
產品
最近的發展

Natus Medical Incorporated

公司簡介
公司收入
產品
最近的發展

Elekta

公司簡介
公司收入
產品
最近的發展

Natus Medical Incorporated

公司簡介
公司收入
產品
最近的發展

Pfizer Inc.

公司簡介
公司收入
產品
最近的發展

Civco Medical Solutions

公司簡介
公司收入
產品
最近的發展

Novartis AG

公司簡介
公司收入
產品
最近的發展

Maico Diagnostics GmbH

公司簡介
公司收入
產品
最近的發展

Siemens Healthcare GmbH

公司簡介
公司收入
產品
最近的發展

Interacoustics A/S

公司簡介
公司收入
產品
最近的發展

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR112115228

The global demand for Acoustic Neuroma Market is presumed to reach the market size of nearly USD 4.06 Billion by 2032 from USD 2.04 Billion in 2023 with a CAGR of 7.96% under the study period 2024-2032.

Acoustic neuroma is a non-cancerous growth that arises on the eighth cranial nerve, linking the inner ear directly to the brain. This slow-growing tumor arises from Schwann cells, which produce the myelin sheath covering nerve fibers. Symptoms often include hearing loss, tinnitus (ringing in the ear), and balance disturbances. In some cases, it can cause facial numbness or weakness. While its exact cause is unclear, genetic factors, such as neurofibromatosis type 2 (NF2), can increase the risk. Treatment options vary and can include regular monitoring, surgical removal, or radiation therapy, depending on factors such as the tumor's size, growth rate, and the patient's overall health.

MARKET DYNAMICS

The increasing prevalence of acoustic neuroma is the primary factor driving market growth. With advancements in diagnostic techniques, more cases of acoustic neuroma are being detected early, leading to higher demand for effective treatments. Innovations in surgical procedures, such as minimally invasive surgeries and stereotactic radiosurgery, have significantly improved patient outcomes, boosting the market. The rising awareness among patients and healthcare providers about this condition and its symptoms has led to more frequent diagnoses and interventions. The aging population is another critical factor, as this condition is more likely to develop in older adults. Furthermore, government initiatives and funding for research into acoustic neuroma and related neurological conditions provide a significant impetus for market expansion. Collaboration between research institutions and pharmaceutical companies to develop novel therapies also plays a crucial role in driving market growth. Rising investment in healthcare infrastructure, especially in developing countries, is expected to provide new market opportunities. However, the high cost of treatment and potential side effects may challenge market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Acoustic Neuroma. The growth and trends of Acoustic Neuroma industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Acoustic Neuroma market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Devices
Drugs (Systemic Steroids, Antiviral Medicatior, Vasodilators Others)

By Disease Type

Conductive Hearing Loss
Sensorineural Hearing Loss Mixed
Mixed (Conductive And Sensorineural)

By End-User

Hospitals
Otology Clinics
Ambulatory Clinics

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Acoustic Neuroma market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Acoustic Neuroma market include F. Hoffmann-La Roche AG, Amgen, Roche, Natus Medical Incorporated, Elekta, Natus Medical Incorporated, Pfizer Inc., Civco Medical Solutions, Novartis AG, Maico Diagnostics GmbH, Siemens Healthcare GmbH, Interacoustics A/S. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. ACOUSTIC NEUROMA - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Disease Type
- 3.7.3 Market Attractiveness Analysis By End-User
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL ACOUSTIC NEUROMA MARKET ANALYSIS BY PRODUCT

5.1. Overview By Product
5.2. Historical and Forecast Data Analysis By Product
5.3. Devices Historic and Forecast Sales By Regions
5.4. Drugs (Systemic Steroids, Antiviral Medicatior, Vasodilators Others) Historic and Forecast Sales By Regions

6. GLOBAL ACOUSTIC NEUROMA MARKET ANALYSIS BY DISEASE TYPE

6.1. Overview By Disease Type
6.2. Historical and Forecast Data Analysis By Disease Type
6.3. Conductive Hearing Loss Historic and Forecast Sales By Regions
6.4. Sensorineural Hearing Loss Mixed Historic and Forecast Sales By Regions
6.5. Mixed (Conductive And Sensorineural) Historic and Forecast Sales By Regions

7. GLOBAL ACOUSTIC NEUROMA MARKET ANALYSIS BY END-USER

7.1. Overview By End-User
7.2. Historical and Forecast Data Analysis By End-User
7.3. Hospitals Historic and Forecast Sales By Regions
7.4. Otology Clinics Historic and Forecast Sales By Regions
7.5. Ambulatory Clinics Historic and Forecast Sales By Regions

8. GLOBAL ACOUSTIC NEUROMA MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE ACOUSTIC NEUROMA COMPANIES

9.1. Acoustic Neuroma Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF ACOUSTIC NEUROMA INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. F. Hoffmann-La Roche AG
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Amgen
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Roche
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Natus Medical Incorporated
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Elekta
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Natus Medical Incorporated
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Pfizer Inc.
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Civco Medical Solutions
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Novartis AG
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Maico Diagnostics GmbH
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments
10.13. Siemens Healthcare GmbH
- 10.13.1 Company Overview
- 10.13.2 Company Revenue
- 10.13.3 Products
- 10.13.4 Recent Developments
10.14. Interacoustics A/S
- 10.14.1 Company Overview
- 10.14.2 Company Revenue
- 10.14.3 Products
- 10.14.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

簡介目錄圖表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Product (USD MN)
Devices Market Sales By Geography (USD MN)
Drugs (Systemic Steroids, Antiviral Medicatior, Vasodilators Others) Market Sales By Geography (USD MN)
Analysis By Disease Type (USD MN)
Conductive Hearing Loss Market Sales By Geography (USD MN)
Sensorineural Hearing Loss Mixed Market Sales By Geography (USD MN)
Mixed (Conductive And Sensorineural) Market Sales By Geography (USD MN)
Analysis By End-User (USD MN)
Hospitals Market Sales By Geography (USD MN)
Otology Clinics Market Sales By Geography (USD MN)
Ambulatory Clinics Market Sales By Geography (USD MN)
Global Acoustic Neuroma Market Sales By Geography (USD MN)
North America Market Analysis (USD MN)
United States Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate By Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Acoustic Neuroma Report
Market Research Process
Market Research Methodology
Global Acoustic Neuroma Market Size, By Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis By Product
Market Attractiveness Analysis By Disease Type
Market Attractiveness Analysis By End-User
Market Attractiveness Analysis By Region
Value Chain Analysis
Global Market Analysis By Product (USD MN)
Devices Market Sales By Geography (USD MN)
Drugs (Systemic Steroids, Antiviral Medicatior, Vasodilators Others) Market Sales By Geography (USD MN)
Global Market Analysis By Disease Type (USD MN)
Conductive Hearing Loss Market Sales By Geography (USD MN)
Sensorineural Hearing Loss Mixed Market Sales By Geography (USD MN)
Mixed (Conductive And Sensorineural) Market Sales By Geography (USD MN)
Global Market Analysis By End-User (USD MN)
Hospitals Market Sales By Geography (USD MN)
Otology Clinics Market Sales By Geography (USD MN)
Ambulatory Clinics Market Sales By Geography (USD MN)
Global Market Sales (USD MN)
North America Market Sales (USD MN)
Europe Market Sales (USD MN)
Asia Pacific Market Sales (USD MN)
Latin America Market Sales (USD MN)
Middle East & Africa Market Sales (USD MN)
Recent Development in Industry
Top Company Market Share Analysis